US Senate Passes Bill for Nearly $250 Billion in Science Funding

The legislation, which now heads to the House, aims to ensure the country can compete with China technologically by supporting research and development over the next five years.

Written byChristie Wilcox, PhD
| 2 min read
The US Senate Chamber with the Capitol Building in the background.

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: The US Senate Chamber entrance.
© ISTOCK.COM, DRNADIG

The Senate passed the US Innovation and Competitiveness Act—a massive science funding bill that aims to help the US compete with China technologically—on Tuesday (June 8) with a 68–32 vote. If the bill passes the House, it would provide $250 billion for research and help foster collaborations between academia and industry.

The act’s bipartisan support, with 48 Democrats, 19 Republicans, and one Independent voting in favor, reflects rising concerns about America’s dependence on China, reports The New York Times. “Either we can concede the mantle of global leadership to our adversaries or we can pave the way for another generation of American leadership,” says Democratic Senate majority leader and cosponsor of the legislation Chuck Schumer (D-NY), according to the Times. The paper calls the bill “the most significant government intervention in industrial policy in decades.”

Overall, the legislation would authorize roughly $190 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies